Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.
Clinical trial NCT04877496 · UNKNOWN
Trial details
- NCT number
- NCT04877496
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-26
- Primary completion
- 2021-08-30
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.